Evidence map›Paper›PMID 36297868›Full record

ArticlePolymers2022

Fe(III)-Rhamnoxylan-A Novel High Spin Fe(III) Octahedral Complex Having Versatile Physical and Biological Properties.

Anum Hayat, Mohammad Saeed Iqbal, Naveed Ahmad, Nabil K Alruwaili, Atta Ur Rehman

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Anum HayatDepartment of Chemistry, Forman Christian College, Lahore 54600, Pakistan.ORCID 0000-0003-0943-1520
Mohammad Saeed IqbalDepartment of Chemistry, Forman Christian College, Lahore 54600, Pakistan.ORCID 0000-0002-2933-195X
Naveed AhmadDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72388, Al-Jouf, Saudi Arabia.ORCID 0000-0003-2312-3137
Nabil K AlruwailiDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72388, Al-Jouf, Saudi Arabia.
Atta Ur RehmanDepartment of Pharmacy, Forman Christian College, Lahore 54600, Pakistan.
Forman Christian College · PKJouf University · SAKinnaird College for Women University · PK

Funding

The Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia 375213500
6 · The paper itself

Abstract

An iron (III) complex with rhamnoxylan, a hemicellulose from Salvia plebeia seeds, was synthesized and characterized by elemental analysis, spectroscopic and magnetic susceptibility measurements, thermal analysis and scanning electron microscopy. The rhamnoxylan was found to be a branched hemicellulose consisting of β-1,4-linked xylose main chain and rhamnose attached to the chain at β-1,3 positions. The complex was found to contain 18.8% w/w iron. A high-spin octahedral geometry of Fe3+ was indicated by the electronic absorption spectrum of the complex. In other experiments, the complex exhibited good electrical and magnetic properties. In vivo efficacy, as hematinic, of the complex in induced anemia was demonstrated equivalent to that of iron protein succinylate (taken as standard) as evidenced by raised red blood cell count, hemoglobin, hematocrit and total iron in rabbit. The complex was found to be non-toxic with LD50 > 5000 mg kg−1 body weight in rabbit. Thus, iron(III)-rhamnoxylan hold the potential for application as hematinic for treatment of iron deficiency anemia.

Indexed as

hematinicIron(III)-hemicellulose complexiron supplementmagnetic polymerrhamnoxylan

Identifiers

PMID36297868
PMCPMC9611695
OpenAlexW4304776093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.